Key Laboratory for Organic Electronics and Information Displays & Institute of Advanced Materials (IAM), Jiangsu National Synergetic Innovation Center for Advanced Materials (SICAM), Nanjing University of Posts and Telecommunications , 9 Wenyuan Road, Nanjing 210023, People's Republic of China.
Key Laboratory of Flexible Electronics (KLOFE) and Institute of Advanced Materials (IAM), Jiangsu National Synergetic Innovation Center for Advanced Materials (SICAM), Nanjing Tech University (NanjingTech) , 30 South Puzhu Road, Nanjing 211816, China.
Biomacromolecules. 2017 Oct 9;18(10):3375-3386. doi: 10.1021/acs.biomac.7b01029. Epub 2017 Sep 13.
Near-infrared (NIR) absorbing nanoagents with functions of photoacoustic imaging (PAI) and photothermal therapy (PTT) have received great attention for cancer therapy. However, endowing them with multifunctions, especially targeting ability, for enhancing in vivo PAI/PTT generally suffers from the problems of synthetic complexity and low surface density of function groups. We herein report high density glycopolymers coated perylenediimide nanoparticles (PLAC-PDI NPs), self-assembled by poly(lactose)-modified perylenediimide (PLAC-PDI), as tumor-targeted PAI/PTT nanoagents. Atom transfer radical polymerization and click reaction were used in sequence to prepare PLAC-PDI, which can accurately control the content of poly(lactose) (PLAC) in PLAC-PDI and endow PLAC-PDI NPs with high density PLAC surface. The high density PLAC surface provided NPs with long-time colloidal stability, outstanding stability in serum and light, and specific targeting ability to cancer cells and tumors. Meanwhile, PLAC-PDI NPs also presented high photothermal conversion efficiency of 42% by virtue of strong π-π interactions among perylenediimide molecules. In living mice, PAI experiments revealed that PLAC-PDI NPs exhibited effective targeting ability and enhanced PTT efficacy to HepG2 tumor compared with control groups, lactose blocking, and ASGP-R negative tumor groups. Overall, our work provids new insights for designing glycopolymers-based therapeutic nanoagents for efficient tumor imaging and antitumor therapy.
具有光声成像(PAI)和光热治疗(PTT)功能的近红外(NIR)吸收纳米制剂在癌症治疗中受到了广泛关注。然而,为了增强体内 PAI/PTT 的效果,赋予它们多功能,尤其是靶向能力,通常会遇到合成复杂和功能基团表面密度低的问题。在此,我们报告了高密度糖聚合物包覆的苝二酰亚胺纳米粒子(PLAC-PDI NPs),它是由聚(乳糖)修饰的苝二酰亚胺(PLAC-PDI)自组装而成的,是一种肿瘤靶向的 PAI/PTT 纳米制剂。原子转移自由基聚合和点击反应被依次用于制备 PLAC-PDI,这可以精确控制聚(乳糖)(PLAC)在 PLAC-PDI 中的含量,并赋予 PLAC-PDI NPs 高密度的 PLAC 表面。高密度的 PLAC 表面使 NPs 具有长时间的胶体稳定性、优异的血清和光照稳定性以及对癌细胞和肿瘤的特异性靶向能力。同时,由于苝二酰亚胺分子之间的强 π-π 相互作用,PLAC-PDI NPs 还表现出 42%的高光热转换效率。在活小鼠中,PAI 实验表明,与对照组、乳糖阻断组和 ASGP-R 阴性肿瘤组相比,PLAC-PDI NPs 对 HepG2 肿瘤具有有效的靶向能力和增强的 PTT 效果。总的来说,我们的工作为设计基于糖聚合物的治疗性纳米制剂以实现高效的肿瘤成像和抗肿瘤治疗提供了新的思路。